Medical Condition News

RSS

Karolinska researchers study four siblings affected by early-onset Alzheimer's disease

Four siblings in a family affected by early-onset Alzheimer's have been studied by a group of researchers at Karolinska Institutet in Sweden. This has been a unique opportunity to make comparative studies and to monitor the development of the disease over a prolonged period of time.

27 May 2011

Preparticipation cardiac screening required for college athletes

Sudden cardiac death in young athletes who had not previously exhibited symptoms is a relatively rare yet tragic event. This occurs in around 60-80 young athletes annually in the United States.

27 May 2011

NILVAD consortium awarded €6 million grant to develop new Alzheimer's disease treatment

An international research consortium led by Trinity College Dublin that aims to develop a new Alzheimer's disease treatment has just been selected for grant funding of €6 million by the European Commission Seventh Framework Programme (FP7).

27 May 2011

Phadia ImmunoCAP Specific IgE blood test used in largest cross-sectional allergy study

Phadia, the worldwide leader of in vitro allergy diagnostics, is pleased to contribute to the largest cross-sectional allergy study ever conducted through the use of its ImmunoCAP Specific IgE blood test, the market leading in vitro allergy diagnostic test.

27 May 2011

Ten changes medical oncologists can do to flatten costs, improve care

The cost of cancer care is threatening to bankrupt our healthcare system. New drugs are prolonging life, but at staggering costs. This coupled with aging baby boomers and an increasing population mean the U.S. will spend $173 billion annually on cancer care by the year 2020. This trend is not sustainable; however, there are evidence-based ways to maintain or improve the quality of care while saving money for the new therapies being discovered every day.

27 May 2011

D3 Oncology Solutions provides six-month free trial period for Via Oncology Pathways program

D3 Oncology Solutions today announced that it will provide its Via Oncology Pathways for a six-month free trial period to enable cancer programs to align the timing of their investment with a strategy for sharing potential savings with payors and other key stakeholders.

27 May 2011

Study: Cardiovascular disease may be under treated in rheumatoid arthritis patients

Results of a study, involving 98,454 patients demonstrated that at 30 days following their first heart attack, RA patients were approximately 20% less likely to be prescribed standard MI treatments, such as statins and betablockers, compared to healthy patients.

27 May 2011

Report: Only 2% of nation's substance abuse treatment facilities offer counseling services in Asian languages

A new report shows that only 2-percent (291) of the nation's 13,513 substance abuse treatment facilities provide counseling services in various Asian languages. The report also showed that the proportion of facilities offering these services varied by geographic region.

27 May 2011

Life Technologies launches new genomic analysis software

Addressing the issue of data overload from next-generation sequencers, Life Technologies Corporation today launched its LifeScope 2.0 Genomic Analysis Software, a significantly enhanced bioinformatics system for analyzing data from genomic sequencing instruments to study human disease such as cancer.

27 May 2011

ASH announces approval of official health care taxonomy code for Designated Specialists

Today the American Society of Hypertension, Inc. (ASH) and the ASH Specialist Program Inc. announced the approval of an official health care taxonomy code for Designated Specialists in Clinical Hypertension from the American Medical Association National Uniform Claims Committee.

27 May 2011

IDF applauds Representatives for Medicare IVIG Access Act

The Immune Deficiency Foundation applauds Representatives Kevin Brady and Doris Matsui and Senators John Kerry and Lamar Alexander for introducing H.R. 1845 and S. 960, both entitled the Medicare IVIG Access Act.

27 May 2011

Transgenomic secures exclusive license from Montefiore for cancer predictive markers

Transgenomic, Inc. announced today that it has acquired an exclusive worldwide license to Montefiore Medical Center's patent application, "Method of Determining the Sensitivity of Cancer Cells to EGFR Inhibitors including cetuximab, panitumumab and erlotinib".

27 May 2011

Innovations in diagnosis and treatment for esophageal cancer

In recent years, the number of cases of adenocarcinoma of the esophagus (or gullet) has been on the rise. At the same time, however, new ways of treatment are improving the outlook for patients. In the current issue of Deutsches Ärzteblatt International, Angelika Behrens and her working group report on innovations in diagnosis and treatment.

27 May 2011

Quest Diagnostics announces results of largest ImmunoCAP cross-sectional allergy study

ImmunoCAP, the worldwide leader of in vitro allergy diagnostics, is pleased to present the results of the largest cross-sectional allergy study ever conducted. The landmark study, announced today by Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information, and services, includes test results from over 2 million patients.

From Quest Diagnostics 27 May 2011

Lactate shuttle also exists in human tumors

Researchers at the Kimmel Cancer Center at Jefferson have shed new light on the longstanding conundrum about what makes a tumor grow-and how to make it stop. Interestingly, cancer cells accelerate the aging of nearby connective tissue cells to cause inflammation, which ultimately provides "fuel" for the tumor to grow and even metastasize.

27 May 2011

New study may provide a more dynamic picture of how teachers respond to stress in real time

After 17 years of researching traumatic stress with war-afflicted populations (veterans and civilians) and job stress in the medical profession, Teresa McIntyre, a research professor in the department of psychology and the Texas Institute for Evaluation, Measurement and Statistics (TIMES), at the University of Houston (UH), decided to study another high risk occupation, middle school teachers in seventh and eighth grade.

27 May 2011

BioDiscovery, Affymetrix enter co-marketing agreement for OncoScan FFPE Express Service

Affymetrix, Inc. today announced a co-marketing agreement naming BioDiscovery, Inc. its preferred software provider for Affymetrix OncoScan FFPE Express Service data analysis.

27 May 2011

Pan-Canadian surgical study offers new hope for patients with early-stage oral cancer

Currently, about 30 per cent of patients who receive oral surgery have their cancer recur. But a new, Canada-wide surgical trial using a new approach to remove tumours and pre-cancerous cells from the mouths of those diagnosed with early-stage oral cancer offers new hope for patients.

27 May 2011

Researchers convert human skin cells directly into functional neurons within four to five weeks

Human skin cells can be converted directly into functional neurons in a period of four to five weeks with the addition of just four proteins, according to a study by researchers at the Stanford University School of Medicine.

27 May 2011

Patients with body dysmorphic disorder have less brain activity in visual processing

People suffering from body dysmorphic disorder, or BDD - a severe mental illness characterized by debilitating misperceptions that one appears disfigured and ugly - process visual information abnormally, even when looking at inanimate objects, according to a new UCLA study.

27 May 2011

Medical Condition News

Karolinska researchers study four siblings affected by early-onset Alzheimer's disease

Preparticipation cardiac screening required for college athletes

NILVAD consortium awarded €6 million grant to develop new Alzheimer's disease treatment

Phadia ImmunoCAP Specific IgE blood test used in largest cross-sectional allergy study

Ten changes medical oncologists can do to flatten costs, improve care

D3 Oncology Solutions provides six-month free trial period for Via Oncology Pathways program

Study: Cardiovascular disease may be under treated in rheumatoid arthritis patients

Report: Only 2% of nation's substance abuse treatment facilities offer counseling services in Asian languages

Life Technologies launches new genomic analysis software

ASH announces approval of official health care taxonomy code for Designated Specialists

IDF applauds Representatives for Medicare IVIG Access Act

Transgenomic secures exclusive license from Montefiore for cancer predictive markers

Innovations in diagnosis and treatment for esophageal cancer

Quest Diagnostics announces results of largest ImmunoCAP cross-sectional allergy study

Lactate shuttle also exists in human tumors

New study may provide a more dynamic picture of how teachers respond to stress in real time

BioDiscovery, Affymetrix enter co-marketing agreement for OncoScan FFPE Express Service

Pan-Canadian surgical study offers new hope for patients with early-stage oral cancer

Researchers convert human skin cells directly into functional neurons within four to five weeks

Patients with body dysmorphic disorder have less brain activity in visual processing

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News